Valeant Targets Shareholders in New Allergan Bid

June 18 (Bloomberg) -- Bloomberg’s Alix Steel reports that Valeant is going hostile in its latest bid for Allergan, making an offer directly to shareholders. She speaks on Bloomberg Television’s “In The Loop.”

Harvard's Burns Sees Mixed U.S. Messages for Europe
01:10 - Harvard Kennedy School Professor Nicholas Burns discusses the concerns of European leaders about President Donald Trump and U.S. foreign policy. He speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Economist O'Sullivan Asks Why Fed Wouldn't Go in March
  • OPEC Has Lost Market Leverage, Says CFR's Richard Haass
  • Medley Global Sees Risk From Two F's: France and the Fed